Litcius/Paper detail

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Mazen Noureddin, Jean L. Chan, Katherine Barradas, Lara Dimick‐Santos, Elmer Schabel, Stephanie O. Omokaro, Frank A. Anania, Robert P. Myers, Veronica Miller, Arun J. Sanyal, Naga Chalasani, Frank A. Anania, Jasmohan S. Bajaj, Katherine Barradas, Annalisa Berzigotti, P Birman, Jaime Bosch, Ashley Brower, Dania Calboli, Naga Chalasani, Jean L. Chan, William Charlton, Klara Dickinson, Lara Dimick‐Santos, Claudia Filozof, Mikael Forsgren, Michael Fuchs, Guadalupe García–Tsao, Juan G. Abraldeṣ, Hans-Juergen Gruss, Morten Hansen, Suneil Hosman, Joanne C. Imperial, David T. Jones, Gadi Lalazar, Olof Dahlqvist Leinhard, Erica Lyons, Brian P McColgan, Ruby Mehta, Peter Mesenbrink, Veronica Miller, Rob Myers, Mazen Noureddin, Stephanie O. Omokaro, Y. Veronica Pei, Vlad Ratziu, Arie Regev, Robert Riccio, Arun J. Sanyal, Elmer Schabel, Suna Seo, Alastair Smith, Peter Szitányi, Peter G. Traber

2020Gastroenterology25 citationsDOIOpen Access PDF

Topics & Concepts

Nonalcoholic steatohepatitisCirrhosisMedicineSteatohepatitisGastroenterologyInternal medicineStakeholderClinical trialEtiologyNonalcoholic fatty liver diseaseFatty liverPolitical sciencePublic relationsDiseaseLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationDiet, Metabolism, and Disease